Companies / Cerevel Therapeutics Holdings, Inc.
Cerevel Therapeutics Holdings, Inc.
CERECIK 1805387
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Aug 1, 2024 | Pfizer Inc | Other Shares tendered | Common Stock | $1.23B | -27.3M -100.00% | 0 | low |
| Oct 16, 2023 | Bain Capital Investors LLC +2 co-filers Director | Buy Open-market buy | Common Stock | $125.00M | +5.5M +9.10% | 65,679,781 | high |
| Aug 16, 2022 | Perceptive Advisors LLC Director | Buy Open-market buy | Common Stock | $49.88M | +1.4M +28.01% | 6,511,727 | high |
| Oct 16, 2023 | Perceptive Advisors LLC Director | Buy Open-market buy | Common Stock | $20.00M | +877K +8.84% | 10,794,876 | high |
| Jun 15, 2023 | Dekkers Marijn E Director | Sell Open-market sale | Common Stock | $6.89M | -200K -33.20% | 402,326 | medium |
| Jul 7, 2021 | Perceptive Advisors LLC Director | Buy Open-market buy | Common Stock | $5.00M | +200K +4.31% | 4,843,095 | high |
| Apr 1, 2024 | Coles N Anthony CEO | Sell Open-market sale | Common Stock | $2.12M | -50K -76.18% | 15,638 | medium |
| Jan 2, 2024 | Coles N Anthony CEO | Sell Open-market sale | Common Stock | $2.11M | -50K -94.87% | 2,704 | medium |